Front Matter
Article Sidebar
Main Article Content
Downloads
Metrics
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright of individual chapters belongs to the respective authors. The authors grant unrestricted publishing and distribution rights to the publisher. The electronic versions of the chapters are published under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). Users are allowed to share and adapt the chapters for any non-commercial purposes as long as the authors and the publisher are explicitly identified and properly acknowledged as the original source. The books in their entirety are subject to copyright by the publisher. The reproduction, modification, republication and display of the books in their entirety, in any form, by anyone, for commercial purposes are strictly prohibited without the written consent of the publisher.
Shashikant Lele, MD, FACOG (Editor), Department of Gynecologic Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA
Shashikant Lele, MD, FACOG, is a Professor of Oncology, Chief of Gynecologic Oncology, and Clinical Chair of the Division of Surgical Subspecialties at the Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. After completing MD degree at JJ Hospital-Grant Medical College, Mumbai, India, he undertook his Residency program at Mount Sinai Hospital, Cleveland, OH, USA. He is certified in Gynecologic Oncology and Obstetrics and Gynecology by the American Board of Obstetrics and Gynecology. His specialization is in cancers of the cervix, endometrium, ovary, uterus, vagina, and vulva with a special interest in Gynecologic Oncology group studies involving clinical and scientific research on ovarian cancer surgery and ovarian cancer chemotherapy. He has given many featured talks including “Women: Listen to Your Body”, an awareness video for women about gynecologic cancers to recognize warning signs so that preemptive approaches can be taken at any sign of irregularity. He has been involved in many clinical trials evaluating novel anticancer chemotherapy of gynecologic cancers. Professor Lele has extensively published in the field including articles in New England Journal of Medicine, Nature Genetics, JAMA Oncology and Journal of Gynecologic Oncology.